SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-180591
Filing Date
2023-06-30
Accepted
2023-06-30 17:15:29
Documents
12
Period of Report
2023-06-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d466366d8k.htm   iXBRL 8-K 25892
  Complete submission text file 0001193125-23-180591.txt   155173

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ikna-20230630.xsd EX-101.SCH 2868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20230630_lab.xml EX-101.LAB 19500
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20230630_pre.xml EX-101.PRE 12168
6 EXTRACTED XBRL INSTANCE DOCUMENT d466366d8k_htm.xml XML 3597
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 231062696
SIC: 2836 Biological Products, (No Diagnostic Substances)